![](/img/cover-not-exists.png)
P-186 * International phase II trial of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients with locally advanced pancreatic cancer (LAPC): LAPACT
Philip, P., Kayitalire, L., Nydam, T., Penenberg, D., Hammel, P.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.186
Date:
June, 2015
File:
PDF, 35 KB
english, 2015